Landcent is now funded by the Bill & Melinda Gates Foundation

In 2019, the Bill & Melinda Gates Foundation signed a partnership of funding with Landcent. Prior to the signing, senior program officers from the foundation visited the Shanghai Institute of Organic Chemistry (SIOC) to better understand the collaborative anti-malarial drug development program between the SIOC, China CDC and Landcent.Among the many things that impressed the foundation was the focus on natural products, which could pave the way for a new generation of anti-malarial technologies.The biggest threat to the eradication of malaria is the growing resistance of parasites to antimalarial drugs and of mosquitoes to the insecticides used in vector control - and these include pyrethroids, organophosphates, carbamates and the occasionally used organochlorine dichlorodiphenyltrichloroethane (DDT). A total of 73 countries have already confirmed resistance to at least one insecticide in one malaria vector species.This is why the WHO has listed as the first in response priority the development of a productive pipeline of new interventions using different modes of action.In light of this Landcent’s framework stood out as the most timely innovation - a micro-encapsulation technology to better change the application of synthetic compounds - making them safe to use and for longer periods of time, and simultaneously the active research and development of natural compounds, which is both sustainable and safe to use at scale.Contact us at info@landcent.com to learn more about the partnership with the Gates Foundation, our joint-lab with the SIOC and our research into natural compounds for malaria prevention and eradication.